Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 27Terminated 6Unknown 5Active not recruiting 3Withdrawn 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 16Myelodysplastic Syndromes 12Multiple Myeloma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Hematologic Neoplasms 6Neuroblastoma 5Hodgkin Disease 5Retinoblastoma 4Lymphoma, Non-Hodgkin 4Graft vs Host Disease 4Anemia, Refractory, with Excess of Blasts 4Myeloproliferative Disorders 3Leukemia, Myelomonocytic, Chronic 3Recurrence 2Primary Myelofibrosis 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Biphenotypic, Acute 2Leukemia, B-Cell 2Leukemia 2Ganglioneuroblastoma 2Anemia, Aplastic 2beta-Thalassemia 1Venentoclax 1Thrombocythemia, Essential 1Sarcoma, Ewing 1Rhabdomyosarcoma 1

Interventions

Cyclophosphamide 29blinatumomab 19Vincristine 16Specimen Handling 13Methotrexate 13Dexamethasone 13fludarabine 12Prednisone 11Cytarabine 11Biopsy 11Doxorubicin 9Asparaginase 9Rituximab 8Mercaptopurine 8Inotuzumab Ozogamicin 8merphos 7Spinal Puncture 7N,N-dicyclohexyl-isoborneol-10-sulfonamide 7Magnetic Resonance Spectroscopy 7venetoclax 6prednylidene 6dexamethasone acetate 6dexamethasone 21-phosphate 6deltacortene 6azathiopurine 6auricularum 6Etoposide 6Daunorubicin 6Calcium Dobesilate 6pegaspargase 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Burkitt Lymphoma × Melphalan × Clear all
NCT05518383 2022-08-26

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 4 Recruiting
300 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡